Retatrutide 20 MG

A next-generation triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. Designed to support significant weight loss and metabolic health improvements.

• Presentation20 MG Cartridge
• ShippingDispatched from Spain · EU-wide
• StorageRefrigerate after reconstitution

Supplied for laboratory research purposes only. Not intended for human consumption or as a substitute for medical advice.